ENSC Insider Trading Activity and SEC Form 4 Filings
ENSC insider trading summary
Over the past 12 months, insiders at Ensysce Biosciences, Inc. (ENSC) reported 2 open-market purchases worth $444K by 1 insider and no sales on SEC Form 4. Net insider buying was $444K.
Latest ENSC insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 7, 2026 | Bob G Gower | Director | Buy | $198K (400,000 @ $0.49) |
| Apr 23, 2026 | Bob G Gower | Director | Buy | $246K (508,614 @ $0.48) |
| Mar 2, 2023 | Bob G Gower | Director | Buy | $44K (90,287 @ $0.49) |
| Mar 1, 2023 | Bob G Gower | Director | Buy | $129K (270,000 @ $0.48) |
| Feb 28, 2023 | Bob G Gower | Director | Buy | $53K (109,300 @ $0.49) |
| Dec 9, 2022 | Bob G Gower | Director | Buy | $500K (357,143 @ $1.40) |
| May 26, 2022 | Lynn Kirkpatrick | Chief Executive Officer | Buy | $14K (27,000 @ $0.53) |
| May 25, 2022 | Lynn Kirkpatrick | Chief Executive Officer | Buy | $34K (70,000 @ $0.49) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.